Pulling the Strings of the Tumor Microenvironment
Claudia Burrello1, Karin E de Visser2,3
1Division of Tumor Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Abstract:
Macrophages are in the spotlight of cancer immunotherapy research because they exert a wide spectrum of protumorigenic functions. In this issue, Pfirschke and colleagues report that macrophage targeting pulls the strings of the tumor microenvironment, ultimately leading to a coordinated antitumorigenic immune reaction in a lung carcinoma mouse model.See related article by Pfirschke et al., p. 40. (4).
Insights
Targeting macrophages in cancer immunotherapy can reprogram the tumor microenvironment. This strategy promotes a coordinated antitumor immune response, offering a novel approach for lung carcinoma treatment.
Area of Science:
- Immunology
- Cancer Research
- Tumor Microenvironment
Background:
- Macrophages play a critical role in cancer, often exhibiting protumorigenic functions.
- Understanding macrophage behavior is key to developing effective cancer immunotherapies.
Purpose of the Study:
- To investigate the impact of macrophage targeting on the tumor microenvironment.
- To determine if modulating macrophages can induce an antitumorigenic immune response.
Main Methods:
- Utilized a lung carcinoma mouse model.
- Employed strategies to target macrophages within the tumor microenvironment.
Main Results:
- Macrophage targeting was shown to significantly influence the tumor microenvironment.
- This manipulation led to a coordinated and effective antitumorigenic immune reaction.
Conclusions:
- Targeting macrophages is a viable strategy to reprogram the tumor microenvironment for cancer immunotherapy.
- This approach holds promise for enhancing antitumor immunity in lung carcinoma.
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


